Synthetic Biology and Biotechnology for Executives: Opportunity, Risk and Strategy

Course overview

A strategic course for leaders who must decide how Synthetic Biology and Biotechnology will affect their organisation. It cuts through the hype to explain the technology, the market outlook, the real opportunities and the risks, regulation and governance that come with them.

Participants finish with a practical adoption roadmap, investment priorities and a plan to build the people and partner capabilities required.

Learning objectives

• Explain Synthetic Biology and Biotechnology in clear business terms
• Assess market trends, opportunities and value pools
• Identify risks, regulation and governance requirements
• Plan capabilities, partnerships and investment
• Lead an adoption roadmap with measurable milestones

Who should attend

Leaders, engineers, innovators and strategy teams preparing their organisations for the next decade.

Daily outline

1. Day 1Why Synthetic Biology and Biotechnology matters: trends and market outlook
2. Day 2Opportunities, use cases and value creation
3. Day 3Risks, regulation, ethics and governance
4. Day 4Building capability: people, partners and technology
5. Day 5Strategy roadmap workshop

Training methodology

Interactive instructor-led sessions, worked examples, group exercises, real case studies, daily quizzes and pre/post assessments. Online sessions run live with the instructor, with recordings and digital materials.

Certificate: ITQAN Global Training certificate of completion for participants who meet attendance requirements and pass the assessment.

Dates and venues 2027–2030

Need other dates or another city? We run this course on demand for groups, anywhere in the world. Corporate & Custom →